These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427 [TBL] [Abstract][Full Text] [Related]
4. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site. Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415 [TBL] [Abstract][Full Text] [Related]
5. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA. Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946 [TBL] [Abstract][Full Text] [Related]
6. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line. Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ Malar J; 2008 Mar; 7():51. PubMed ID: 18364051 [TBL] [Abstract][Full Text] [Related]
7. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy. de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035 [TBL] [Abstract][Full Text] [Related]
8. High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women. McLean ARD; Opi DH; Stanisic DI; Cutts JC; Feng G; Ura A; Mueller I; Rogerson SJ; Beeson JG; Fowkes FJI Front Immunol; 2021; 12():644563. PubMed ID: 34220804 [TBL] [Abstract][Full Text] [Related]
9. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269 [TBL] [Abstract][Full Text] [Related]
10. Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Mayor A; Rovira-Vallbona E; Machevo S; Bassat Q; Aguilar R; Quintó L; Jiménez A; Sigauque B; Dobaño C; Kumar S; Singh B; Gupta P; Chauhan VS; Chitnis CE; Alonso PL; Menéndez C Infect Immun; 2011 Apr; 79(4):1654-9. PubMed ID: 21300778 [TBL] [Abstract][Full Text] [Related]
11. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701 [TBL] [Abstract][Full Text] [Related]
12. Designing a VAR2CSA-based vaccine to prevent placental malaria. Fried M; Duffy PE Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717 [TBL] [Abstract][Full Text] [Related]
13. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates. Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE Elife; 2022 Feb; 11():. PubMed ID: 35103596 [TBL] [Abstract][Full Text] [Related]
14. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129 [TBL] [Abstract][Full Text] [Related]
15. VAR2CSA-Mediated Host Defense Evasion of Tomlinson A; Semblat JP; Gamain B; Chêne A Front Immunol; 2020; 11():624126. PubMed ID: 33633743 [TBL] [Abstract][Full Text] [Related]
16. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design. Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695 [TBL] [Abstract][Full Text] [Related]
17. Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. Beeson JG; Ndungu F; Persson KE; Chesson JM; Kelly GL; Uyoga S; Hallamore SL; Williams TN; Reeder JC; Brown GV; Marsh K Am J Trop Med Hyg; 2007 Jul; 77(1):22-8. PubMed ID: 17620626 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. Tuikue Ndam NG; Salanti A; Le-Hesran JY; Cottrell G; Fievet N; Turner L; Sow S; Dangou JM; Theander T; Deloron P J Infect Dis; 2006 Mar; 193(5):713-20. PubMed ID: 16453268 [TBL] [Abstract][Full Text] [Related]